Profiel
Erich Felber is the founder of Biovertis AG, which was founded in 2003.
He was the Chief Executive Officer of Biovertis AG.
Dr. Felber's former jobs include being the Chief Executive Officer of Micromet AG from 2004 to 2004, Project Leader-Clinical Research at Schering-Plough Corp., and Manager-Strategic Services Group at Accenture LLP.
Dr. Felber's education includes an MBA from INSEAD and a doctorate from Ludwig-Maximilians-Universität München.
Eerdere bekende functies van Erich Felber
| Bedrijven | Functie | Einde |
|---|---|---|
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | President | 01-03-2004 |
Accenture LLP
Accenture LLP Miscellaneous Commercial ServicesCommercial Services Provides strategy, consulting, technology and operations services | Corporate Officer/Principal | - |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Develops small molecule drugs against proprietary microbial antigens | Algemeen Directeur | - |
Opleiding van Erich Felber
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Accenture LLP
Accenture LLP Miscellaneous Commercial ServicesCommercial Services Provides strategy, consulting, technology and operations services | Commercial Services |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Develops small molecule drugs against proprietary microbial antigens | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















